annual cash & cash equivalents:
$10.16B-$2.74B(-21.21%)Summary
- As of today (August 18, 2025), BNTX annual cash & cash equivalents is $10.16 billion, with the most recent change of -$2.74 billion (-21.21%) on December 31, 2024.
- During the last 3 years, BNTX annual cash & cash equivalents has risen by +$8.24 billion (+430.02%).
- BNTX annual cash & cash equivalents is now -31.73% below its all-time high of $14.88 billion, reached on December 31, 2022.
Performance
BNTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$16.03B+$1.19B(+8.03%)Summary
- As of today (August 18, 2025), BNTX quarterly cash & cash equivalents is $16.03 billion, with the most recent change of +$1.19 billion (+8.03%) on June 30, 2025.
- Over the past year, BNTX quarterly cash & cash equivalents has dropped by -$2.50 billion (-13.51%).
- BNTX quarterly cash & cash equivalents is now -14.03% below its all-time high of $18.65 billion, reached on September 30, 2024.
Performance
BNTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BNTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.2% | -13.5% |
| 3 y3 years | +430.0% | +64.3% |
| 5 y5 years | +1646.8% | +2391.1% |
BNTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.7% | +430.0% | -14.0% | +65.4% |
| 5 y | 5-year | -31.7% | +1646.8% | -14.0% | +2391.1% |
| alltime | all time | -31.7% | +4819.7% | -14.0% | +4849.4% |
BNTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $16.03B(+8.0%) |
| Mar 2025 | - | $14.84B(-12.1%) |
| Dec 2024 | $10.16B(-21.2%) | $16.89B(-9.4%) |
| Sep 2024 | - | $18.65B(+0.6%) |
| Jun 2024 | - | $18.54B(+91.2%) |
| Mar 2024 | - | $9.69B(-24.8%) |
| Dec 2023 | $12.89B(-13.4%) | $12.88B(-9.8%) |
| Sep 2023 | - | $14.29B(-7.6%) |
| Jun 2023 | - | $15.46B(+17.1%) |
| Mar 2023 | - | $13.19B(-10.9%) |
| Dec 2022 | $14.88B(+676.4%) | $14.81B(+12.6%) |
| Sep 2022 | - | $13.15B(+34.8%) |
| Jun 2022 | - | $9.76B(+42.3%) |
| Mar 2022 | - | $6.86B(+256.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.92B(+28.8%) | $1.92B(-30.6%) |
| Sep 2021 | - | $2.77B(+155.8%) |
| Jun 2021 | - | $1.08B(+3.5%) |
| Mar 2021 | - | $1.05B(-29.2%) |
| Dec 2020 | $1.49B(+156.0%) | $1.48B(+27.5%) |
| Sep 2020 | - | $1.16B(+80.5%) |
| Jun 2020 | - | $643.58M(+29.9%) |
| Mar 2020 | - | $495.51M(-14.8%) |
| Dec 2019 | $581.54M(+23.5%) | $581.54M(+14.7%) |
| Sep 2019 | - | $506.91M(+56.5%) |
| Jun 2019 | - | $323.92M(-31.2%) |
| Dec 2018 | $470.71M(+128.0%) | $470.71M |
| Dec 2017 | $206.48M(-35.7%) | - |
| Dec 2016 | $321.04M | - |
FAQ
- What is BioNTech SE annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioNTech SE?
- What is BioNTech SE annual cash & cash equivalents year-on-year change?
- What is BioNTech SE quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BioNTech SE?
- What is BioNTech SE quarterly cash & cash equivalents year-on-year change?
What is BioNTech SE annual cash & cash equivalents?
The current annual cash & cash equivalents of BNTX is $10.16B
What is the all time high annual cash & cash equivalents for BioNTech SE?
BioNTech SE all-time high annual cash & cash equivalents is $14.88B
What is BioNTech SE annual cash & cash equivalents year-on-year change?
Over the past year, BNTX annual cash & cash equivalents has changed by -$2.74B (-21.21%)
What is BioNTech SE quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BNTX is $16.03B
What is the all time high quarterly cash & cash equivalents for BioNTech SE?
BioNTech SE all-time high quarterly cash & cash equivalents is $18.65B
What is BioNTech SE quarterly cash & cash equivalents year-on-year change?
Over the past year, BNTX quarterly cash & cash equivalents has changed by -$2.50B (-13.51%)